According to MediaMind (formerly Eyeblaster), mobile ads in a number of industries are showing great response rates and ROI. As the Pharma industry looks to other industries as examples, they certainly need to be (and are) looking at mobile advertising opportunities.
At EHS, we understand this emerging trend and offer marketers who are looking to reach both healthcare professional and consumer audiences a way to test the mobile waters. By including mobile advertising as part of a broader channel buy across our targeted premium network, marketers can minimize risk while assessing reward potential.
Read the MediaMind report for details on its findings.